Swedbank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.14B | Buy |
1,781,310
+165,006
| +10% | +$169M | 1.84% | 10 |
|
|
2026
Q1 | $1.49B | Sell |
1,616,304
-52,647
| -3% | -$53.4M | 1.56% | 9 |
|
|
2025
Q4 | $1.79B | Buy |
1,668,951
+115,688
| +7% | +$111M | 1.74% | 9 |
|
|
2025
Q3 | $1.19B | Buy |
1,553,263
+231,334
| +17% | +$172M | 1.2% | 10 |
|
|
2025
Q2 | $1.03B | Buy |
1,321,929
+66,090
| +5% | +$51.4M | 1.16% | 11 |
|
|
2025
Q1 | $1.04B | Buy |
1,255,839
+116,905
| +10% | +$97.3M | 1.38% | 9 |
|
|
2024
Q4 | $879M | Buy |
1,138,934
+28,426
| +3% | +$23.5M | 1.08% | 15 |
|
|
2024
Q3 | $984M | Sell |
1,110,508
-86,791
| -7% | -$78M | 1.25% | 11 |
|
|
2024
Q2 | $1.08B | Sell |
1,197,299
-1,730
| -0.1% | -$1.38M | 1.45% | 11 |
|
|
2024
Q1 | $933M | Buy |
1,199,029
+46,751
| +4% | +$33.3M | 1.32% | 11 |
|
|
2023
Q4 | $672M | Buy |
1,152,278
+73,826
| +7% | +$43.1M | 1.08% | 18 |
|
|
2023
Q3 | $579M | Buy |
1,078,452
+23,955
| +2% | +$12.3M | 1% | 21 |
|
|
2023
Q2 | $495M | Sell |
1,054,497
-16,564
| -2% | -$6.95M | 0.84% | 30 |
|
|
2023
Q1 | $368M | Buy |
1,071,061
+76,438
| +8% | +$25.8M | 0.73% | 28 |
|
|
2022
Q4 | $364M | Buy |
994,623
+111,856
| +13% | +$39.7M | 0.8% | 28 |
|
|
2022
Q3 | $285M | Buy |
882,767
+181,979
| +26% | +$57.7M | 0.68% | 33 |
|
|
2022
Q2 | $227M | Buy |
700,788
+15,897
| +2% | +$4.77M | 0.51% | 43 |
|
|
2022
Q1 | $196M | Buy |
684,891
+7,327
| +1% | +$1.89M | 0.36% | 55 |
|
|
2021
Q4 | $188M | Sell |
677,564
-24,380
| -3% | -$6.18M | 0.31% | 61 |
|
|
2021
Q3 | $162M | Sell |
701,944
-33,900
| -5% | -$8.37M | 0.3% | 67 |
|
|
2021
Q2 | $169M | Buy |
735,844
+47
| +0% | +$9.44K | 0.32% | 61 |
|
|
2021
Q1 | $137M | Sell |
735,797
-12,136
| -2% | -$2.37M | 0.29% | 76 |
|
|
2020
Q4 | $125M | Buy |
747,933
+170,103
| +29% | +$25.4M | 0.37% | 82 |
|
|
2020
Q3 | $85.5M | Sell |
577,830
-97,075
| -14% | -$15M | 0.29% | 92 |
|
|
2020
Q2 | $111M | Sell |
674,905
-128,559
| -16% | -$19.7M | 0.4% | 77 |
|
|
2020
Q1 | $111M | Sell |
803,464
-57,143
| -7% | -$7.85M | 0.55% | 56 |
|
|
2019
Q4 | $113M | Buy |
+860,607
| New | +$99.8M | 0.46% | 80 |
|
|
2015
Q2 | – | Sell |
-1,066,137
| Closed | -$77.5M | – | 65 |
|
|
2015
Q1 | $77.5M | Sell |
1,066,137
-228,992
| -18% | -$16.3M | 0.6% | 52 |
|
|
2014
Q4 | $89.4M | Buy |
+1,295,129
| New | +$87.4M | 0.69% | 55 |
|
|
2014
Q1 | $77.5M | Buy |
+1,066,137
| New | +$59.5M | 0.6% | 52 |
|
Other funds holding LLY
Swedbank's LLY Position: Q2 2026 in Review
Swedbank increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $169M and bringing the position to 1,781,310 shares worth $2.14B. The position accounts for 1.84% of the portfolio, ranked #10.
Swedbank first reported a position in LLY in Q1 2014 and has held it in 30 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Swedbank held 1,781,310 shares of Eli Lilly worth $2.14B as of Q2 2026.
- Swedbank bought 165,006 Eli Lilly shares in Q2 2026, an estimated $169M.
- Eli Lilly made up 1.84% of Swedbank's portfolio in Q2 2026, its #10 holding.
- Swedbank first reported a position in Eli Lilly in Q1 2014 and has held it in 30 quarters since.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.